Posts Tagged 'memory loss'

Canadian study finds link between Lipitor, diabetes

A new study by Canadian researchers adds to a growing pool of evidence that Lipitor and other types of cholesterol-lowering drugs called statins put patients at a higher risk of developing diabetes.

According to a story on CTV News, researchers published the results of their study in BMJ, a journal of the British Medication Association.

The story notes that previous research has spotlighted a possible link between taking some statins and diabetes, ...

continue reading...

Lipitor sales drop diminishes Pfizer’s outlook for the year

The Wall Street Journal says a dramatic sales drop in Pfizer’s anti-cholesterol medication Lipitor was behind the company’s nine percent revenue decline for the first quarter, which was worse than expected and lowered the company’s full-year outlook.

The U.S. Food and Drug Administration has recently added warnings to the label of Lipitor, advising that the drug may increase the risk of Type II diabetes. The new label also warns that Lipitor ...

continue reading...

Lipitor maker posts lower-than-expected earnings

Pfizer Inc. has posted lower-than-expected earnings and revenue for the first quarter, in part because of rapidly falling sales of the cholesterol drug Lipitor, Reuters reports.

Sales of the drug, formerly a cash cow for the pharmaceutical giant, plummeted 55 percent to $626 million.

The drug has been competing with cheaper generics since November. Recent health concerns about Lipitor have cropped up as well.

The U.S. Food and Drug Administration has added warnings ...

continue reading...

Cholesterol levels dropping, still problematic

The good news is that national cholesterol levels have dropped over the last four decades. The bad news is that they still represent a “significant public health problem,” according to the National Center for Health Statistics, a branch of the Centers for Disease Control and Prevention.

KPCC Public Radio out of California says the NCHS report specifically refers to low-density lipoprotein (LDL) cholesterol, which health providers often refer to as “bad ...

continue reading...

FDA approves new cholesterol medication

Nature World News reports that the U.S. Food and Drug Administration has approved the anti-cholesterol drug Liptruzet.

According to the story, Liptruzet is a combination of Merck’s Zetia, which lowers low-density lipoprotein (LDL), and a generic version of Pfizer’s Lipitor, which lost its patent protection in 2011.

Lipitor has recently generated some health concerns.

The U.S. Food and Drug Administration has added warnings to Lipitor’s label, advising that the medication may increase the ...

continue reading...

Few cholesterol drugs in the works

Despite the fact that high cholesterol triggering heart attacks and strokes is the biggest killer in the United States, few companies are developing new drugs to treat the condition, according to a report in Forbes.

Forbes attributes that situation in part to a series of high profile failures from Pfizer, Merck , and AstraZeneca. Cheap generic versions of popular medicines including Pfizer’s Lipitor have also likely chased off some potential developers.

Lipitor ...

continue reading...
Page 3 of 5 12345